Back to NVCR

Palo Alto Investors LP → NVCR

Palo Alto Investors LP NVCR Position History

NovoCure Limited • Healthcare

Quarters held
6
Latest value
$19.3M
Q3 2026
Peak value
$19.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.8M
Q1 2026$14M
Q2 2026$19.4M
Q2 2026$19.4M
Q2 2026$19.4M
Q3 2026$19.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$19.3M1.21M——
Q2 2026$19.4M1.28M——
Q2 2026$19.4M1.28M——
Q2 2026$19.4M1.28M——
Q1 2026$14M1.28M——
Q4 2025$16.8M1.30M——

Other funds holding NVCR

$706.1M
$686.6M
$565M
$520.7M
$515.5M
$460.8M
$459.4M
$394.4M

Other Palo Alto Investors LP positions

INSM

INSMED INC

$85.2M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
PTCT

PTC THERAPEUTICS INC

$75M
AMSF

AMICUS THERAPEUTICS INC

$74.1M
ACAD

ACADIA PHARMACEUTICALS INC

$72.5M
ACAD

ACADIA PHARMACEUTICALS INC

$72.5M
ACHC

ACADIA PHARMACEUTICALS INC

$72.5M